Newsfeeds Archive - Page 4 of 12

2 minute read

Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug

December 21, 9:54 AM

The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) at

CALT

2 minute read

Analyst Ratings

What 5 Analyst Ratings Have To Say About McKesson

By Benzinga Insights

December 11, 11:00 AM

Within the last quarter, McKesson (NYSE:MCK) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

MCK

2 minute read

How Is The Market Feeling About McKesson?

By Benzinga Insights

December 8, 12:15 PM

McKesson’s (NYSE:MCK) short percent of float has risen 12.5% since its last report. The company recently reported that…

MCK

2 minute read

Teamsters At McKesson In Sacramento, California, Have Voted To Authorize A Strike If The Company Fails To Reach Agreement On A Fair Contract

By Benzinga Newsdesk

December 4, 4:56 PM

https://teamster.org/2023/12/teamsters-authorize-strike-at-mckesson/#:~:text=(SACRAMENTO%2C%20Calif.),current%20contract%20expires%20December%2010. Teamsters at McKesson in Sacramento, Calif., have voted

MCK